Last updated on September 2018

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors


Brief description of study

The purpose of this first-in-human study of CX-2009 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-2009 in adult subjects with metastatic or locally advanced unresectable solid tumors. PROCLAIM: PRObody CLinical Assessment In Man CX-2009 clinical trial 001

PROBODY is a trademark of CytomX Therapeutics, Inc

Clinical Study Identifier: NCT03149549

Contact Investigators or Research Sites near you

Start Over

Lori Carman

Yale University School of Medicine - Yale Cancer Center
New Haven, CT United States
  Connect »

Lori Carman

University of Chicago
Chicago, IL United States
  Connect »

Lori Carman

Indiana University Health Melvin and Bren Simon Cancer Center
Indianapolis, IN United States
  Connect »

Lori Carman

Memorial Sloan Kettering Cancer Center
New York, NY United States
  Connect »

Lori Carman

University Hospitals Cleveland Medical Center
Cleveland, OH United States
  Connect »

Lori Carman

Providence Portland Medical Center
Portland, OR United States
  Connect »

Lori Carman

The Sarah Cannon Research Institute
Nashville, TN United States
  Connect »

Lori Carman

Mary Crowley Medical Research Center
Dallas, TX United States
  Connect »

Lori Carman

Viriginia Cancer Specialists
Fairfax, VA United States
  Connect »

Lori Carman

USC Norris Comprehensive Cancer Center
Los Angeles, CA United States
  Connect »

Lori Carman

Dana-Farber Cancer Institute
Boston, MA United States
  Connect »

Lori Carman

Barbara Ann Karmanos Cancer Institute
Detroit, MI United States
  Connect »

Lori Carman

Roswell Park Cancer Institute
Buffalo, NY United States
  Connect »

Lori Carman

MD Anderson Cancer Center
Houston, TX United States
  Connect »

Lori Carman

Huntsman Cancer Institute
Salt Lake City, UT United States
  Connect »

Lori Carman

Swedish Cancer Institute (SCI)
Seattle, WA United States
  Connect »

Lori Carman

University of Wisconsin-Carbone Cancer Center
Madison, WI United States
  Connect »

Lori Carman

Hospital Clinic Barcelona
Barcelona, Spain
  Connect »

Lori Carman

Centro Integral Oncologico Clara Campal
Madrid, Spain
  Connect »

Lori Carman

University of California, Los Angeles (UCLA) - Medical Center
Santa Monica, CA United States
  Connect »

Lori Carman

Rush University Medical Center
Chicago, IL United States
  Connect »

Lori Carman

New York University (NYU) Clinical Cancer Center
New York, NY United States
  Connect »

Lori Carman

Columbia University College of Physicians & Surgeons, Columbia University
New York, NY United States
  Connect »

Lori Carman

Amsterdam UMC - Locatie VUmc
Amsterdam, Netherlands
  Connect »

Lori Carman

Universitair Medisch Centrum Groningen
Groningen, Netherlands
  Connect »

Lori Carman

Instituto Catalan de Oncologia - Hospital Duran i Reynals
Barcelona, Spain
  Connect »

Lori Carman

Instituto Valenciano de Oncologia
Valencia, Spain
  Connect »

Lori Carman

Sarah Cannon Research Institute UK Limited
London, United Kingdom
  Connect »

Lori Carman

Clinica Universidad de Navarra
Pamplona, Spain
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.